Platinum Investment Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-302,120
Closed -$5.43M 143
2022
Q3
$5.43M Hold
302,120
0.23% 48
2022
Q2
$3.75M Buy
302,120
+106,909
+55% +$1.18M 0.14% 59
2022
Q1
$2.6M Hold
195,211
0.08% 75
2021
Q4
$3.04M Hold
195,211
0.08% 82
2021
Q3
$4.38M Hold
195,211
0.12% 70
2021
Q2
$4.45M Sell
195,211
-28,872
-13% -$607K 0.1% 68
2021
Q1
$4.61M Hold
224,083
0.1% 56
2020
Q4
$6.19M Sell
224,083
-27,556
-11% -$536K 0.14% 54
2020
Q3
$3.54M Sell
251,639
-53,591
-18% -$997K 0.09% 64
2020
Q2
$6.29M Sell
305,230
-35,414
-10% -$482K 0.14% 46
2020
Q1
$2.57M Buy
340,644
+75,263
+28% +$844K 0.06% 64
2019
Q4
$4.12M Sell
265,381
-35,235
-12% -$355K 0.08% 49
2019
Q3
$1.56M Buy
300,616
+62,218
+26% +$462K 0.04% 71
2019
Q2
$2.16M Buy
238,398
+91,846
+63% +$1.37M 0.05% 53
2019
Q1
$3.5M Hold
146,552
0.08% 48
2018
Q4
$2.4M Buy
146,552
+75,152
+105% +$1.48M 0.08% 41
2018
Q3
$1.9M Buy
71,400
+17,200
+32% +$389K 0.05% 54
2018
Q2
$1.24M Hold
54,200
0.03% 66
2018
Q1
$1.15M Buy
+54,200
New +$825K 0.03% 68

Other funds holding MYOV

Platinum Investment Management's MYOV Position: Q4 2022 in Review

Platinum Investment Management sold out of Myovant Sciences Ltd. (MYOV) in Q4 2022, closing a stake of 302,120 shares — an estimated $5.43M sold.

Platinum Investment Management first reported a position in MYOV in Q1 2018 and held it in 19 quarters. The position peaked at $6.29M in Q2 2020. 118 funds tracked by Wall St. Rank hold MYOV as of Q4 2022.

  • Platinum Investment Management reported no remaining Myovant Sciences Ltd. position as of Q4 2022 after selling out during the quarter.
  • Platinum Investment Management sold 302,120 Myovant Sciences Ltd. shares in Q4 2022, an estimated $5.43M.
  • Platinum Investment Management first reported a position in Myovant Sciences Ltd. in Q1 2018 and held it in 19 quarters.
  • Platinum Investment Management's Myovant Sciences Ltd. position peaked at $6.29M in Q2 2020.
  • 118 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2022.

Based on Platinum Investment Management's 13F filing for Q4 2022, filed 13 Feb 2023.